Dopamine D1/D5 receptor signaling is involved in arrhythmogenesis in the setting of takotsubo cardiomyopathy

BackgroundPrevious studies suggested involvement of non-ß-adrenoceptors in the pathogenesis of Takotsubo cardiomyopathy (TTC). This study was designed to explore possible roles and underlying mechanisms of dopamine D1/D5 receptor coupled signaling in arrhythmogenesis of TTC.MethodsHuman-induced plur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huang, Mengying (Autor) , Yang, Zhen (Autor) , Li, Yingrui (Autor) , Lan, Huan (Autor) , Cyganek, Lukas (Autor) , Yücel, Gökhan (Autor) , Lang, Siegfried (Autor) , Bieback, Karen (Autor) , El-Battrawy, Ibrahim (Autor) , Zhou, Xiao-Bo (Autor) , Borggrefe, Martin (Autor) , Akın, Ibrahim (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 04 February 2022
In: Frontiers in Cardiovascular Medicine
Year: 2022, Volumen: 8, Pages: 1-15
ISSN:2297-055X
DOI:10.3389/fcvm.2021.777463
Acceso en línea:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fcvm.2021.777463
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/article/10.3389/fcvm.2021.777463
Enlace del recurso
Notas de Autor:Mengying Huang, Zhen Yang, Yingrui Li, Huan Lan, Lukas Cyganek, Goekhan Yuecel, Siegfried Lang, Karen Bieback, Ibrahim El-Battrawy, Xiaobo Zhou, Martin Borggrefe and Ibrahim Akin
Descripción
Sumario:BackgroundPrevious studies suggested involvement of non-ß-adrenoceptors in the pathogenesis of Takotsubo cardiomyopathy (TTC). This study was designed to explore possible roles and underlying mechanisms of dopamine D1/D5 receptor coupled signaling in arrhythmogenesis of TTC.MethodsHuman-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were challenged by toxic concentration of epinephrine (Epi, 0.5 mM for 1 h) for mimicking the catecholamine excess in setting of TTC. Specific receptor blockers and activators were used to unveil roles of D1/D5 receptors. Patch clamp, qPCR, and FACS analyses were performed in the study.ResultsHigh concentration Epi and two dopamine D1/D5 receptor agonists [(±)-SKF 38393 and fenoldopam] reduced the depolarization velocity and prolonged the duration of action potentials (APs) and caused arrhythmic events in iPSC-CMs, suggesting involvement of dopamine D1/D5 receptor signaling in arrhythmogenesis associated with QT interval prolongation in the setting of TTC. (±)-SKF 38393 and fenoldopam enhanced the reactive oxygen species (ROS)-production. H2O2 (100 μM) recapitulated the effects of (±)-SKF 38393 and fenoldopam on APs and a ROS-blocker N-acetylcysteine (NAC, 1 mM) abolished the effects, suggesting that the ROS-signaling is involved in the dopamine D1/D5 receptor actions. A NADPH oxidases blocker and a PKA- or PKC-blocker suppressed the effects of the dopamine receptor agonist, implying that PKA, NADPH oxidases and PKC participated in dopamine D1/D5 receptor signaling. The abnormal APs resulted from dopamine D1/D5 receptor activation-induced dysfunctions of ion channels including the Na+ and L-type Ca2+ and IKr channels.ConclusionsDopamine D1/D5 receptor signaling plays important roles for arrhythmogenesis of TTC. Dopamine D1/D5 receptor signaling in cardiomyocytes might be a potential target for treating arrhythmias in patients with TTC.
Notas:Gesehen am 04.03.2022
Descripción Física:Online Resource
ISSN:2297-055X
DOI:10.3389/fcvm.2021.777463